These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 32547394)

  • 21. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
    Drago L; De Vecchi E; Nicola L; Gismondo MR
    BMC Infect Dis; 2007 Sep; 7():111. PubMed ID: 17888153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ex vivo Ceftolozane/Tazobactam Clearance during Continuous Renal Replacement Therapy.
    Chaijamorn W; Shaw AR; Lewis SJ; Mueller BA
    Blood Purif; 2017; 44(1):16-23. PubMed ID: 28237981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal infusion rate in antimicrobial therapy explosion of evidence in the last five years.
    Zhu LL; Zhou Q
    Infect Drug Resist; 2018; 11():1105-1117. PubMed ID: 30127628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delirium Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).
    Teng C; Frei CR
    Drugs Real World Outcomes; 2022 Mar; 9(1):23-29. PubMed ID: 34275113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007-2009 study.
    Zhanel GG; Adam HJ; Low DE; Blondeau J; Decorby M; Karlowsky JA; Weshnoweski B; Vashisht R; Wierzbowski A; Hoban DJ;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):291-306. PubMed ID: 21353957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial defined daily dose in neonatal population.
    Villanueva-Bueno C; Montecatine-Alonso E; Jiménez-Parrilla F; Fernández-Llamazares CM; Manrique-Rodríguez S; Zamora-Flores E; Dolz E; Fernández-Polo A; Catillo-Salinas F; Comuñas J; Gallego-Fernández C; González-López M; Gómez-Trevecedo Calvo MT; Gázquez-Pérez R; Álvarez Del Vayo-Benito C; Gil-Navarro MV;
    Enferm Infecc Microbiol Clin (Engl Ed); 2022 Feb; 40(2):59-65. PubMed ID: 35120651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia.
    Henderson A; Tan E; McCarthy KL; Paterson DL
    Pathology; 2018 Dec; 50(7):748-752. PubMed ID: 30392710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 5-year Surveillance Study on Antimicrobial Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital.
    Maraki S; Mantadakis E; Mavromanolaki VE; Kofteridis DP; Samonis G
    Infect Chemother; 2016 Sep; 48(3):190-198. PubMed ID: 27659437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens*.
    Jamal JA; Udy AA; Lipman J; Roberts JA
    Crit Care Med; 2014 Jul; 42(7):1640-50. PubMed ID: 24674926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial defined daily dose in neonatal population.
    Villanueva-Bueno C; Montecatine-Alonso E; Jiménez-Parrilla F; Fernández-Llamazares CM; Manrique-Rodríguez S; Zamora-Flores E; Dolz E; Fernández-Polo A; Catillo-Salinas F; Comuñas J; Gallego-Fernández C; González-López M; Gómez-Trevecedo Calvo MT; Gázquez-Pérez R; Álvarez Del Vayo-Benito C; Gil-Navarro MV;
    Enferm Infecc Microbiol Clin (Engl Ed); 2021 Jun; ():. PubMed ID: 34183175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Monte Carlo Simulation Approach for Beta-Lactam Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.
    Jang SM; Gharibian KN; Lewis SJ; Fissell WH; Tolwani AJ; Mueller BA
    J Clin Pharmacol; 2018 Oct; 58(10):1254-1265. PubMed ID: 29746711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI).
    Kongnakorn T; Eckmann C; Bassetti M; Tichy E; Di Virgilio R; Baillon-Plot N; Charbonneau C
    Antimicrob Resist Infect Control; 2019; 8():204. PubMed ID: 31890160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
    Wang H; Chen MJ;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):385-90. PubMed ID: 12820914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic Dosing for Critically Ill Adult Patients Receiving Intermittent Hemodialysis, Prolonged Intermittent Renal Replacement Therapy, and Continuous Renal Replacement Therapy: An Update.
    Hoff BM; Maker JH; Dager WE; Heintz BH
    Ann Pharmacother; 2020 Jan; 54(1):43-55. PubMed ID: 31342772
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of susceptibility profiles of Gram-negative bacteria before and after the introduction of ertapenem at a medical center in northern Taiwan from 2004 to 2010.
    Lee CM; Lai CC; Wang YY; Lee MC; Hsueh PR
    Diagn Microbiol Infect Dis; 2013 Jan; 75(1):94-100. PubMed ID: 23116904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.
    Zhanel GG; DeCorby M; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; Mulvey MR; Hoban DJ;
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):67-80. PubMed ID: 18513913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cefepime Dosing in a Critically Ill Neonate Receiving Continuous Renal Replacement Therapy With the Cardio-Renal Pediatric Dialysis Emergency Machine (CARPEDIEM).
    Toy C; Stimes G; Moore M; Srivaths P; Arikan AA
    J Pediatr Pharmacol Ther; 2023; 28(2):167-171. PubMed ID: 37139247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.
    Heintz BH; Matzke GR; Dager WE
    Pharmacotherapy; 2009 May; 29(5):562-77. PubMed ID: 19397464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study.
    Zhanel GG; Adam HJ; Baxter MR; Fuller J; Nichol KA; Denisuik AJ; Lagacé-Wiens PR; Walkty A; Karlowsky JA; Schweizer F; Hoban DJ;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i7-22. PubMed ID: 23587781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.